Cannabix Technologies reported the detection of Methamphetamine and Amphetamine compounds in human breath samples using its Marijuana Breath Test (MBT) platform. The update is an incremental validation of product capability rather than a quantified financial or regulatory milestone, so near-term impact is likely limited.
Cannabix Technologies reported the detection of Methamphetamine and Amphetamine compounds in human breath samples using its Marijuana Breath Test (MBT) platform. The update is an incremental validation of product capability rather than a quantified financial or regulatory milestone, so near-term impact is likely limited.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.10
Ticker Sentiment
